中华微生物学和免疫学杂志
中華微生物學和免疫學雜誌
중화미생물학화면역학잡지
Chinese Journal of Microbiology and Immunology
2015年
9期
692-697
,共6页
李世福%付金翠%李再友%郭春园%许杰%赵金仙%高良敏
李世福%付金翠%李再友%郭春園%許傑%趙金仙%高良敏
리세복%부금취%리재우%곽춘완%허걸%조금선%고량민
艾滋病%HIV/HCV混合感染%疾病进展%CD4+T淋巴细胞计数%死亡
艾滋病%HIV/HCV混閤感染%疾病進展%CD4+T淋巴細胞計數%死亡
애자병%HIV/HCV혼합감염%질병진전%CD4+T림파세포계수%사망
AIDS%HIV/HCV co-infection%Disease progression%CD4+T cell counts%Death
目的:对静脉注射吸毒人群中HIV感染者与HIV/HCV混合感染者的疾病进展及死亡情况进行对比分析,探讨HIV/HCV混合感染对HIV感染者自然病程的影响。方法对2006—2014年间吸毒人群哨点监测报告的HIV单独感染者与HIV/HCV混合感染者进行回顾性研究,获取CD4+T淋巴细胞计数数据,通过艾滋病综合防治信息系统获得HIV/AIDS死亡的相关数据,两组人群进行对比分析。结果175例HIV单独感染者首次CD4+T淋巴细胞计数平均值为370个/μl,且小于200个/μl的为25.71%,月均CD4+T 淋巴细胞计数自然变化速率为:-1.50个/μl,1年内病死率为18.18%,352例HIV/HCV混合感染者首次CD4+T 淋巴细胞计数平均值为420个/μl,且小于200个/μl的为20.45%,月均CD4+T 淋巴细胞计数自然变化速率为:-2.76个/μl,1年内病死率为32.14%,两组人群差异均有统计学意义(P<0.05)。结论与HIV单独感染者相比,HIV/HCV混合感染者被发现时免疫状况尚可,但是其CD4+T淋巴细胞计数下降速度较快,疾病进展快,死亡速度也较快。必须加快制定针对HIV/HCV混合感染者的防治策略。
目的:對靜脈註射吸毒人群中HIV感染者與HIV/HCV混閤感染者的疾病進展及死亡情況進行對比分析,探討HIV/HCV混閤感染對HIV感染者自然病程的影響。方法對2006—2014年間吸毒人群哨點鑑測報告的HIV單獨感染者與HIV/HCV混閤感染者進行迴顧性研究,穫取CD4+T淋巴細胞計數數據,通過艾滋病綜閤防治信息繫統穫得HIV/AIDS死亡的相關數據,兩組人群進行對比分析。結果175例HIV單獨感染者首次CD4+T淋巴細胞計數平均值為370箇/μl,且小于200箇/μl的為25.71%,月均CD4+T 淋巴細胞計數自然變化速率為:-1.50箇/μl,1年內病死率為18.18%,352例HIV/HCV混閤感染者首次CD4+T 淋巴細胞計數平均值為420箇/μl,且小于200箇/μl的為20.45%,月均CD4+T 淋巴細胞計數自然變化速率為:-2.76箇/μl,1年內病死率為32.14%,兩組人群差異均有統計學意義(P<0.05)。結論與HIV單獨感染者相比,HIV/HCV混閤感染者被髮現時免疫狀況尚可,但是其CD4+T淋巴細胞計數下降速度較快,疾病進展快,死亡速度也較快。必鬚加快製定針對HIV/HCV混閤感染者的防治策略。
목적:대정맥주사흡독인군중HIV감염자여HIV/HCV혼합감염자적질병진전급사망정황진행대비분석,탐토HIV/HCV혼합감염대HIV감염자자연병정적영향。방법대2006—2014년간흡독인군초점감측보고적HIV단독감염자여HIV/HCV혼합감염자진행회고성연구,획취CD4+T림파세포계수수거,통과애자병종합방치신식계통획득HIV/AIDS사망적상관수거,량조인군진행대비분석。결과175례HIV단독감염자수차CD4+T림파세포계수평균치위370개/μl,차소우200개/μl적위25.71%,월균CD4+T 림파세포계수자연변화속솔위:-1.50개/μl,1년내병사솔위18.18%,352례HIV/HCV혼합감염자수차CD4+T 림파세포계수평균치위420개/μl,차소우200개/μl적위20.45%,월균CD4+T 림파세포계수자연변화속솔위:-2.76개/μl,1년내병사솔위32.14%,량조인군차이균유통계학의의(P<0.05)。결론여HIV단독감염자상비,HIV/HCV혼합감염자피발현시면역상황상가,단시기CD4+T림파세포계수하강속도교쾌,질병진전쾌,사망속도야교쾌。필수가쾌제정침대HIV/HCV혼합감염자적방치책략。
Objective To comparatively analyze the HIV disease progression and the death situa-tion between injecting drug users (IDUs) with HIV infection and those with HIV/HCV co-infection.Meth-ods The counts of CD4+T cells were collected through a retrospective study and the data about death situa-tion were collected with follow-up cards from 2006 to 2014 .A statistical analysis was conducted for the two groups .Results Among the 175 cases with HIV infection , the average value of primary CD 4+T cell counts was 370 cell/μl and 25.71%of them, primary CD4+T cell counts were less than 200 cell/μl.The average change rate of CD4+T cell counts was -1.50 cell/μl in month.The annual mortality rate was 18.18%. Among the 325 cases with HIV/HCV co-infection, the average value of primary CD4+T cell counts was 420 cell/μl and 20.45%of them, primary CD4+T cell counts were less than 200 cell/μl.The average change rate of CD4+T cell counts was -2.76 cell/μl in month.The annual mortality rate was 32.14%.The differ-ences between the groups were significant (P<0.05).Conclusion Compared with patients with HIV infec-tion, those with HIV/HCV co-infection showed significantly decreased CD 4+T cell counts , resulting in a faster disease progression and a faster death .It was urgent for the management department to work out HIV prevention and therapeutic measures .